Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Parenteral Nutrition Market

ID: MRFR/HC/41726-HCR
111 Pages
Rahul Gotadki
March 2026

Parenteral Nutrition Market Research Report: Size, Share, Trend Analysis By Product Type (Total Parenteral Nutrition, Partial Parenteral Nutrition, Intravenous Fat Emulsions, Amino Acid Solutions, Carbohydrates Solutions), By Route of Administration (Central Venous Catheter, Peripheral Venous Catheter, Implantable Port), By End Users (Hospitals, Homecare Settings, Ambulatory Surgical Centers, Nursing Facilities), By Component (Amino Acids, Dextrose, Lipids, Vitamins, Electrolytes) andBy Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Parenteral Nutrition Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF

Parenteral Nutrition Market Summary

As per MRFR analysis, the Global Parenteral Nutrition Market size was valued at USD 5.49 Billion in 2024. The market is projected to grow from USD 5.712 Billion in 2025 to USD 8.496 Billion by 2035, exhibiting a CAGR of 4.0% during the forecast period 2025-2035. North America led the market with over 40.7% share, generating around USD 2.2 billion in revenue.
 
The Parenteral Nutrition Market is growing steadily, driven by rising chronic disease prevalence, an aging population, and increasing demand for nutritional support in hospitals and homecare. Key trends include technological innovations in formulations and delivery systems, expansion of personalized nutrition solutions, and a shift toward outpatient and home-based care models that enhance patient outcomes.

Key Market Trends & Highlights

The Global Parenteral Nutrition Market is experiencing robust growth driven by technological advancements and increasing demand for personalized nutrition.

  • North America remains the largest market for parenteral nutrition, driven by advanced healthcare infrastructure and high awareness levels.
  • The Asia-Pacific region is emerging as the fastest-growing market, fueled by rising healthcare investments and an expanding patient population.
  • Total Parenteral Nutrition Market holds the largest market share, while Partial Parenteral Nutrition Market is witnessing the fastest growth due to increasing home healthcare services.
  • Key market drivers include the rising prevalence of chronic diseases and the aging population, which are propelling demand for nutritional support.

Market Size & Forecast

2024 Market Size 5.49 (USD Billion)
2035 Market Size 8.496 (USD Billion)
CAGR (2025 - 2035) 4.05%

Major Players

Companies such as Baxter International Inc (US), Fresenius Kabi AG (DE), B. Braun Melsungen AG (DE), Hospira Inc (US), Otsuka Pharmaceutical Co Ltd (JP), Eagle Pharmaceuticals Inc (US), Grifols SA (ES), Nutricia (NL), Parenteral Drug Association (US) are some of the major participants in the global parenteral nutrition market.

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

Parenteral Nutrition Market Trends

The Global Parenteral Nutrition Market is currently experiencing a notable transformation, driven by advancements in medical technology and an increasing prevalence of chronic diseases. This market encompasses a range of nutritional products administered intravenously, catering to patients who are unable to consume food orally. The growing awareness of the importance of nutrition in patient recovery and overall health management is propelling demand for parenteral nutrition solutions.

Furthermore, the rise in outpatient care and home healthcare services is reshaping the landscape, as more patients seek convenient and effective nutritional support outside traditional hospital settings. In addition, The Global Parenteral Nutrition Market is witnessing a shift towards personalized nutrition solutions. Healthcare providers are increasingly recognizing the need for tailored nutritional therapies that address individual patient requirements.

This trend is likely to enhance patient outcomes and satisfaction, as customized formulations can better meet the unique metabolic needs of diverse patient populations. As the market evolves, regulatory frameworks are also adapting to ensure safety and efficacy, which may further influence product development and market dynamics in the coming years.

Technological Advancements

The Global Parenteral Nutrition Market is benefiting from continuous technological innovations. Enhanced delivery systems and improved formulations are making parenteral nutrition more effective and safer for patients. These advancements are likely to streamline administration processes and reduce complications associated with intravenous feeding.

Rising Demand for Home Healthcare

There is a growing trend towards home healthcare services, which is influencing The Global Parenteral Nutrition Market. Patients are increasingly opting for nutritional support at home, driven by convenience and comfort. This shift is prompting manufacturers to develop products that are suitable for home use, thereby expanding market reach.

Focus on Personalized Nutrition

The emphasis on personalized medicine is becoming more pronounced within The Global Parenteral Nutrition Market. Healthcare professionals are recognizing the importance of individualized nutritional therapies, which can lead to better patient outcomes. This trend suggests a move towards customized parenteral nutrition solutions that cater to specific patient needs.

Parenteral Nutrition Market Drivers

Aging Population

The demographic shift towards an aging population is poised to impact The Global Parenteral Nutrition Industry substantially. Older adults frequently experience malnutrition due to various factors, including decreased appetite and underlying health conditions. It is estimated that nearly 30% of elderly individuals in healthcare settings are malnourished, which underscores the necessity for effective nutritional support.
 
As the global population aged 65 and over continues to expand, the demand for parenteral nutrition products is likely to increase, prompting healthcare systems to adapt their nutritional strategies to meet the needs of this vulnerable demographic.

Expansion of Home Healthcare Services

The expansion of home healthcare services is emerging as a crucial driver for The Global Parenteral Nutrition Industry. As more patients prefer receiving care in the comfort of their homes, the demand for home-based parenteral nutrition solutions is on the rise. Recent statistics indicate that the home healthcare market is projected to grow at a compound annual growth rate of over 7% in the coming years.
 
This shift not only reflects changing patient preferences but also highlights the need for convenient and effective nutritional support options, thereby creating new opportunities for market players to develop and supply parenteral nutrition products tailored for home use.

Rising Awareness of Nutritional Support

There is a growing awareness among healthcare professionals and patients regarding the importance of nutritional support in clinical settings, which is influencing The Global Parenteral Nutrition Industry. Educational initiatives and research highlighting the benefits of parenteral nutrition in improving recovery times and overall health outcomes are becoming more widespread.
 
This increased awareness is likely to drive demand, as healthcare providers are more inclined to implement parenteral nutrition protocols for patients who cannot meet their nutritional needs through oral intake. Consequently, this trend may lead to a more significant market presence for parenteral nutrition products.

Advancements in Nutritional Formulations

Innovations in nutritional formulations are driving growth within The Global Parenteral Nutrition Industry. The development of specialized products that cater to specific patient needs, such as those with metabolic disorders or renal insufficiencies, is becoming increasingly prevalent.
 
Recent advancements have led to the introduction of new amino acid solutions and lipid emulsions that enhance the efficacy of parenteral nutrition. This evolution in product offerings not only improves patient outcomes but also expands the market by attracting healthcare providers seeking the latest solutions for their patients' nutritional requirements.

Increasing Prevalence of Chronic Diseases

The rising incidence of chronic diseases such as diabetes, cancer, and gastrointestinal disorders is a primary driver for The Global Parenteral Nutrition Industry. As these conditions often necessitate specialized nutritional support, the demand for parenteral nutrition solutions is expected to grow.
 
According to recent data, approximately 60% of hospital patients require some form of nutritional intervention, with parenteral nutrition being a critical component for those unable to consume food orally. This trend indicates a significant market opportunity, as healthcare providers increasingly recognize the importance of tailored nutritional therapies in managing chronic illnesses.

Market Segment Insights

By Type: Total Parenteral Nutrition (Largest) vs. Partial Parenteral Nutrition (Fastest-Growing)

In The Global Parenteral Nutrition, Total Parenteral Nutrition (TPN) commands the largest market share, primarily due to its ability to provide comprehensive nutritional support to patients unable to consume food orally. This segment comprises intricate formulations that address specific needs, thereby solidifying its dominance in critical care settings. In contrast, Partial Parenteral Nutrition (PPN) is gaining traction, increasingly adopted in outpatient settings where patients require additional nutritional support alongside oral intake, indicating a diversification in patient treatment protocols.

TPN (Dominant) vs. PPN (Emerging)

Total Parenteral Nutrition (TPN) serves as the foundation of parenteral nutrition therapy, focusing on delivering complete nutrients directly into the bloodstream. This approach is essential for patients with severe gastrointestinal disorders or post-surgical recovery who cannot tolerate oral nutrition. Conversely, Partial Parenteral Nutrition (PPN) offers a more flexible solution, supplementing oral intake with essential nutrients and emerging as a favored option among healthcare providers. As healthcare trends shift towards more personalized patient care, PPN's ability to combine oral and parenteral routes allows it to adapt to individual nutritional needs more effectively, supporting its position as an emerging segment in the market.

By Route of Administration: Central Venous Catheters (Largest) vs. Peripheral Venous Catheters (Fastest-Growing)

In The Global Parenteral Nutrition Market, central venous catheters (CVCs) hold the largest market share due to their established effectiveness for long-term nutrient delivery in patients requiring extended nutrition therapy. They provide a reliable access point for high-volume and concentrated nutrient solutions, making them the preferred choice among healthcare professionals. Conversely, peripheral venous catheters, while smaller in market share, showcase significant growth owing to their simplicity and reduced risk profile for short-term infusions, appealing especially to outpatient and less critical settings.

CVCs (Dominant) vs. Peripheral Catheters (Emerging)

Central venous catheters, as the dominant segment in The Global Parenteral Nutrition Market, are essential for patients needing long-term nutritional support due to their capacity for high flow rates and multi-lumen options. They are favored in critical care situations and complex cases requiring constant monitoring. On the other hand, peripheral venous catheters represent an emerging category that is gaining traction due to their easier insertion and lower complication rates. This makes them increasingly popular for outpatient parenteral nutrition, catering to a growing demand for less invasive alternatives while still effectively delivering essential nutrients.

By End User: Hospitals (Largest) vs. Homecare Settings (Fastest-Growing)

In The Global Parenteral Nutrition Market, Hospitals remain the largest end-user segment, significantly influencing overall market dynamics. Their dominance can be attributed to the rising numbers of patients requiring specialized nutritional support, especially those with conditions that impair normal digestion. Hospitals provide comprehensive care and have established protocols for parenteral nutrition, ensuring that they continue to capture the largest share of the market. On the other hand, Homecare Settings are emerging as the fastest-growing segment in this arena. The shift towards home-based healthcare solutions, combined with increasing awareness about the benefits of at-home parenteral nutrition, has propelled growth in this sector. Patients are increasingly opting for homecare management, driven by preferences for comfort and reduced hospital stays, leading to a surge in demand for homecare parenteral nutrition solutions.

Hospitals (Dominant) vs. Homecare Settings (Emerging)

Hospitals are characterized by their vast infrastructure, specialized medical staff, and advanced equipment, making them the dominant force in the parenteral nutrition landscape. They play a crucial role in administering complex treatments and managing patients with severe malnutrition or underlying health conditions necessitating nutritional support. Their established networks ensure reliable access to parenteral nutrition products and services. Conversely, Homecare Settings are emerging rapidly as patient-centric solutions gain traction. This segment is characterized by the convenience it offers to patients who prefer receiving care in familiar environments. Homecare providers are adapting their services to cater to the growing demand, offering flexible delivery systems and support, thereby positioning themselves strategically in a competitive market.

By Component: Amino Acids (Largest) vs. Lipids (Fastest-Growing)

In The Global Parenteral Nutrition Market, the component segment is primarily driven by Amino Acids, which hold the largest market share among all the components. Following closely are Dextrose and Lipids, with Lipids gaining traction due to their essential role in providing a higher caloric density in parenteral formulations. Vitamins and Electrolytes trail behind but are critical for overall patient nutrition management, ensuring a comprehensive approach to dietary needs in parenteral therapies. The growth trends within this segment highlight a rising demand for tailored nutritional solutions, especially for patients with chronic illnesses or those recovering from surgery. The increasing prevalence of gastrointestinal disorders and cancer, along with advancements in parenteral nutrition formulations, are key drivers of this growth trend. Additionally, the emphasis on personalized medicine is spurring innovation in Amino Acids and Lipids, marking them as focal points for future market expansion.

Amino Acids (Dominant) vs. Dextrose (Emerging)

Amino Acids serve as the dominant component in The Global Parenteral Nutrition Market due to their critical role in protein synthesis, essential for healing and maintaining muscle mass in patients unable to consume food orally. Their formulation is pivotal in addressing the unique requirements of patients undergoing various treatments. On the other hand, Dextrose is emerging as a significant player in the market, primarily due to its ability to provide an immediate source of energy. While traditionally used in carbohydrate-restricted diets, Dextrose is increasingly being recognized for its versatile application in surgical recovery protocols and managing diabetic patients. The combination of these two components showcases the market's shift toward more integrated nutritional strategies.

Get more detailed insights about Parenteral Nutrition Market
Request Free Sample

Regional Insights

The Regional segment of the Global Parenteral Nutrition Market presents a diverse and evolving landscape, with North America leading as a dominant player valued at 2.1 USD Billion in 2024 and expected to grow to 3.2 USD Billion by 2035. This region holds a significant share due to advanced healthcare infrastructure and increased demand for nutritional support in clinical practices. Europe follows, valued at 1.5 USD Billion in 2024 and projected to reach 2.4 USD Billion by 2035, reflecting strong market growth driven by increasing awareness of parenteral nutrition benefits.

The APAC region, valued at 1.0 USD Billion in 2024 and growing to 1.6 USD Billion by 2035, showcases a considerable opportunity due to expanding healthcare access and rising incidences of chronic diseases. South America, though smaller, shows potential with a valuation of 0.5 USD Billion in 2024 and expected growth to 0.8 USD Billion by 2035, indicating a gradual increase in healthcare initiatives.

The MEA region, valued at 0.3 USD Billion in 2024 and projected to grow to 0.5 USD Billion by 2035, highlights an emerging market driven by improving healthcare systems and increasing investments in medical nutrition.Overall, these regional insights underscore the importance of market growth and evolving dynamics in the Global Parenteral Nutrition Market revenue.

Parenteral Nutrition Market Regional Image

Key Players and Competitive Insights

The Global Parenteral Nutrition Market has witnessed significant developments over the past few years, driven by an increasing demand for effective nutritional support in clinical settings, especially for patients who cannot consume food orally. This market is characterized by intense competition among key players who strive to innovate and enhance their product offerings to cater to diverse patient needs.
 
As the prevalence of chronic diseases and conditions that require nutritional intervention continues to rise, companies within this sector are focusing on expanding their market presence, forming strategic partnerships, and improving their distribution channels. The competitive landscape showcases a mix of established companies and emerging players, each vying for a share of the growing market.
 
Abbott Laboratories holds a prominent position in the Global Parenteral Nutrition Market, capitalizing on its extensive portfolio of advanced nutritional products designed for various patient demographics. The company's strengths lie in its robust research and development capabilities, which enable it to create innovative solutions that address specific nutritional deficiencies. Abbott Laboratories has established a strong reputation for quality and safety in their products, making it a trusted choice for healthcare professionals and patients alike.
 
The company's extensive distribution network allows for efficient delivery of its parenteral nutrition solutions across multiple regions, ensuring that it can meet the demands of healthcare institutions and patients. Furthermore, Abbott's commitment to clinical research enhances its credibility and fosters trust in its nutritional offerings.Nutricia, a subsidiary of Danone, is another key player in the Global Parenteral Nutrition Market, recognized for its specialized focus on clinical nutrition. The company emphasizes the importance of tailoring nutritional solutions to meet the unique needs of patients, particularly those with specific medical conditions requiring parenteral nutrition.
 
Nutricia's strengths lie in its deep understanding of patient needs and its innovative product development strategies that are based on sound scientific research. Their portfolio includes a range of high-quality parenteral nutrition products, which have gained acceptance and endorsement within the medical community. Nutricia's global presence and strategic collaborations with healthcare providers allow it to effectively penetrate various markets and respond to the evolving demands of the healthcare landscape, solidifying its position as a trusted provider in the field of parenteral nutrition.

Key Companies in the Parenteral Nutrition Market include

Industry Developments

  • Q2 2024: Baxter Announces FDA Approval of Clinimix E with Omega-3s for Parenteral Nutrition Market in the U.S. Baxter International Inc. received FDA approval for its Clinimix E with Omega-3s, a new parenteral nutrition formulation designed to provide essential fatty acids and protein for critically ill patients in the United States.
  • Q1 2024: Fresenius Kabi Launches SmofKabiven Peripheral in Europe Fresenius Kabi announced the European launch of SmofKabiven Peripheral, a multi-chamber bag for parenteral nutrition, expanding its portfolio of ready-to-use intravenous nutrition solutions.
  • Q2 2024: Otsuka Pharmaceutical Factory Opens New Parenteral Nutrition Market Manufacturing Facility in Japan Otsuka Pharmaceutical Factory inaugurated a new manufacturing facility in Naruto, Japan, dedicated to the production of parenteral nutrition solutions to meet growing domestic and international demand.
  • Q1 2024: B. Braun Expands Parenteral Nutrition Market Production Capacity in Germany B. Braun announced the expansion of its parenteral nutrition production facility in Melsungen, Germany, to increase output and support rising demand across Europe.
  • Q2 2024: Grifols Receives EMA Approval for New Parenteral Nutrition Market Product in Europe Grifols S.A. received European Medicines Agency (EMA) approval for its new amino acid-based parenteral nutrition product, enabling broader distribution across the European Union.
  • Q3 2024: Kelun Pharmaceutical Signs Strategic Partnership with Libang HealthCare for Parenteral Nutrition Market Distribution in China Kelun Pharmaceutical entered a strategic partnership with Libang HealthCare Group to expand the distribution of its parenteral nutrition products throughout China.
  • Q2 2024: Baxter International Announces Acquisition of Orbisana Healthcare GmbH Baxter International completed the acquisition of Orbisana Healthcare GmbH, strengthening its presence in the European parenteral nutrition market.
  • Q1 2024: Fresenius Kabi Receives FDA Approval for Kabiven Peripheral in the U.S. Fresenius Kabi received FDA approval for Kabiven Peripheral, a triple-chamber bag for parenteral nutrition, expanding its U.S. product portfolio.
  • Q2 2024: Otsuka Pharmaceutical Factory Launches New Amino Acid Solution for Parenteral Nutrition Market in Japan Otsuka Pharmaceutical Factory launched a new amino acid solution for parenteral nutrition, designed to improve protein intake for hospitalized patients in Japan.
  • Q3 2024: B. Braun Appoints New Head of Parenteral Nutrition Market Division B. Braun announced the appointment of a new executive to lead its parenteral nutrition division, aiming to drive innovation and growth in the sector.
  • Q2 2024: Fresenius Kabi Invests €100 Million in New Parenteral Nutrition Market Plant in France Fresenius Kabi announced a €100 million investment to build a new parenteral nutrition manufacturing plant in France, expected to boost supply for European markets.
  • Q1 2024: Baxter International Signs Supply Agreement with Major U.S. Hospital Network for Parenteral Nutrition Market Products Baxter International signed a multi-year supply agreement with a leading U.S. hospital network to provide parenteral nutrition products, strengthening its market position in North America.

Future Outlook

Parenteral Nutrition Market Future Outlook

The Parenteral Nutrition Market size is projected to reach USD 8.496 Billion by 2035, growing at a CAGR of 4.0%

New opportunities lie in:

  • Development of personalized parenteral nutrition solutions for specific patient demographics. Expansion of telehealth services for remote monitoring of parenteral nutrition patients. Investment in automated compounding systems to enhance efficiency and safety in production.

By 2035, the market is expected to achieve robust growth, reflecting evolving healthcare needs and technological advancements.

Market Segmentation

Parenteral Nutrition Market Type Outlook

  • Total Parenteral Nutrition
  • Partial Parenteral Nutrition
  • Intravenous Fat Emulsions
  • Amino Acid Solutions
  • Carbohydrates Solutions

Parenteral Nutrition Market End User Outlook

  • Hospitals
  • Homecare Settings
  • Ambulatory Surgical Centers
  • Nursing Facilities

Parenteral Nutrition Market Component Outlook

  • Amino Acids
  • Dextrose
  • Lipids
  • Vitamins
  • Electrolytes

Parenteral Nutrition Market Route of Administration Outlook

  • Central Venous Catheters
  • Peripheral Venous Catheters
  • Implantable Ports

Report Scope

MARKET SIZE 2024 5.49(USD Billion)
MARKET SIZE 2025 5.712(USD Billion)
MARKET SIZE 2035 8.496(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 4.05% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Billion
Key Companies Profiled Baxter International Inc (US), Fresenius Kabi AG (DE), B. Braun Melsungen AG (DE), Hospira Inc (US), Otsuka Pharmaceutical Co Ltd (JP), Eagle Pharmaceuticals Inc (US), Grifols SA (ES), Nutricia (NL), Parenteral Drug Association (US)
Segments Covered Product Type, Route of Administration, End Users, Component, Regional
Key Market Opportunities Advancements in personalized nutrition solutions enhance patient outcomes in The Global Parenteral Nutrition.
Key Market Dynamics Rising demand for personalized nutrition solutions drives innovation and competition in the parenteral nutrition market.
Countries Covered North America, Europe, APAC, South America, MEA
Author
Author
Author Profile
Rahul Gotadki LinkedIn
Research Manager
He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.
Get In Touch
Leave a Comment

FAQs

What is the projected market valuation of The Global Parenteral Nutrition by 2035?

<p>The projected market valuation for The Global Parenteral Nutrition is 8.496 USD Billion by 2035.</p>

What was the market valuation of The Global Parenteral Nutrition in 2024?

<p>The overall market valuation was 5.49 USD Billion in 2024.</p>

What is the expected CAGR for The Global Parenteral Nutrition during the forecast period 2025 - 2035?

<p>The expected CAGR for The Global Parenteral Nutrition during the forecast period 2025 - 2035 is 4.05%.</p>

Which companies are considered key players in The Global Parenteral Nutrition?

<p>Key players in the market include Baxter International Inc, Fresenius Kabi AG, B. Braun Melsungen AG, and others.</p>

What are the main segments of The Global Parenteral Nutrition?

<p>The main segments include Total Parenteral Nutrition, Partial Parenteral Nutrition, and Intravenous Fat Emulsions.</p>

How much is the Total Parenteral Nutrition segment expected to grow by 2035?

<p>The Total Parenteral Nutrition segment is expected to grow from 2.2 USD Billion in 2024 to 3.4 USD Billion by 2035.</p>

What is the projected growth for the Central Venous Catheters segment by 2035?

<p>The Central Venous Catheters segment is projected to grow from 2.2 USD Billion in 2024 to 3.4 USD Billion by 2035.</p>

What is the expected market size for Homecare Settings in 2035?

<p>The expected market size for Homecare Settings is projected to reach 1.8 USD Billion by 2035.</p>

Which component of parenteral nutrition is anticipated to see the highest growth by 2035?

<p>Dextrose is anticipated to see the highest growth, increasing from 1.5 USD Billion in 2024 to 2.2 USD Billion by 2035.</p>

What is the expected market size for Nursing Facilities by 2035?

<p>The expected market size for Nursing Facilities is projected to reach 1.4 USD Billion by 2035.</p>

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓